Rasbach Kyle
SEC CIK 2050086 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | CFO | 40.9K | — | — | 1 | 2025-01-17 | 2025-01-17 |
Most active insiders at LXEO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Townsend Richard Nolan | CEO, Dir | — | $655.7K |
| 2 | Bhalla Narinder Pal | Chief Medical Off | — | $98.6K |
| 3 | Otero Jose Manuel | Chief Technical Off | — | $78.9K |
| 4 | Tamayo Louis Edward | CFO | — | $41.0K |
| 5 | See Tai Sandi | Chief Development Off | — | $38.4K |
| 6 | Robertson Jenny | CLO | — | $36.6K |
| 7 | Adler Eric | Chief Medical Off | — | $36.0K |
Rasbach Kyle made no open-market trades at LXEO in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-22 | 2025-01-17 | LXEO | Lexeo Therapeutics, Inc. | Rasbach Kyle | CFO | A - Grant | $0.00 | +40.9K | 40.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations